Cancer proteomics: New opportunities for old molecules?

Daniel W. Chan; Shu Ling Liang

doi:10.1007/BF02752495

Cancer proteomics: New opportunities for old molecules?

Daniel W. Chan
, Shu Ling Liang

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	129-132
Number of pages	4
Journal	Clinical Proteomics
Volume	2
Issue number	3-4
DOIs	https://doi.org/10.1007/BF02752495
State	Published - Dec 2006

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Clinical Biochemistry

Access to Document

10.1007/BF02752495

Cite this

@article{3ca4ad2176124e3f8bc98040c3de8b1c,

title = "Cancer proteomics: New opportunities for old molecules?",

author = "Chan, \{Daniel W.\} and Liang, \{Shu Ling\}",

year = "2006",

month = dec,

doi = "10.1007/BF02752495",

language = "English (US)",

volume = "2",

pages = "129--132",

journal = "Clinical Proteomics",

issn = "1542-6416",

publisher = "BioMed Central",

number = "3-4",

}

TY - JOUR

T1 - Cancer proteomics

T2 - New opportunities for old molecules?

AU - Chan, Daniel W.

AU - Liang, Shu Ling

PY - 2006/12

Y1 - 2006/12

UR - https://www.scopus.com/pages/publications/46649086945

UR - https://www.scopus.com/pages/publications/46649086945#tab=citedBy

U2 - 10.1007/BF02752495

DO - 10.1007/BF02752495

M3 - Editorial

AN - SCOPUS:46649086945

SN - 1542-6416

VL - 2

SP - 129

EP - 132

JO - Clinical Proteomics

JF - Clinical Proteomics

IS - 3-4

ER -

Cancer proteomics: New opportunities for old molecules?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this